ElendiLabs — Regulatory consultancy platform connecting medical device and pharmaceutical manufacturers with verified experts worldwide
All regulatory hubs
Regulatory hub

Overview of the Czech Office for Technical Standardization, Metrology and State Testing (ÚNMZ) and Medical Device Regulation

An overview of ÚNMZ's role in the Czech Republic, focusing on medical device standards, conformity assessment, and the supervision of notified bodies under the EU MDR.

Overview

Summary of this regulator or jurisdiction and how it relates to market access.

Official regulator site

Czech Office for Technical Standardization, Metrology and State Testing (ÚNMZ) - Medical Devices Overview

The Czech Office for Technical Standardization, Metrology and State Testing (ÚNMZ) is a state administration body under the Ministry of Industry and Trade of the Czech Republic. In the medical devices sector, ÚNMZ primarily oversees technical standardization, metrology, and the designation and supervision of Notified Bodies (Authorized Organizations) responsible for conformity assessment.

Regulatory Framework

Medical device regulation in the Czech Republic complies strictly with the European Union's New Legislative Framework (NLF):

  • EU Medical Device Regulation (MDR) 2017/745: Replaces the older Council Directive 93/42/EEC and outlines general safety and performance requirements.
  • National Legislation: Supported by Act No. 89/2021 Coll. on medical devices, Act No. 90/2016 Coll., and accompanying decrees (Decree No. 186/2021 Coll. and Decree No. 170/2021 Coll.).

Key Roles and Responsibilities of ÚNMZ

  • Notified Bodies Oversight: ÚNMZ authorizes and supervises the bodies conducting conformity assessments. In the Czech Republic, notable entities include:

  • AO 201: Electrotechnical Testing Institute (Elektrotechnický zkušební ústav, s.p. - EZÚ)

  • AO 224: Institute for Testing and Certification (Institut pro testování a certifikaci, a.s. - ITC)

  • Technical Standardization: Ensures the integration of harmonized European standards under the MDR into national frameworks to guide domestic manufacturers.

  • Metrology and State Testing: Regulates measuring equipment and testing protocols to ensure accuracy in medical applications.

  • Annex XVI Products: Handles the expanded regulation under MDR for products without an intended medical purpose (e.g., non-prescription colored contact lenses, dermal fillers, liposuction devices, IPL epilators).

While market surveillance and professional acts are shared with the State Institute for Drug Control (SÚKL), ÚNMZ serves as the foundational authority for technical quality, conformity infrastructure, and standardization.

Articles & guides

Insight articles mapped to this region on ElendiLabs.

Registration

January 20, 2026

Czech Republic Act No. 50/2022: Pharmaceuticals Act Amendment for Medical Devices and IVDs

Act No. 50/2022 Sb. amends the Czech Pharmaceuticals Act to incorporate provisions related to medical devices and IVDs, including definitions, competent authority powers, registration, vigilance integration, advertising controls, and sanctions, aligning national law with EU MDR/IVDR requirements effective 2022.

Read article

Registration

January 15, 2026

Czech Republic Act No. 172/2022: In Vitro Diagnostic Medical Devices Regulation Implementation

Act No. 172/2022 Sb. transposes EU IVDR 2017/746 into Czech law, specifying national competent authority (SÚKL), registration duties, Czech language labelling, advertising restrictions, vigilance procedures, clinical performance study approvals, and administrative penalties, effective from 2022.

Read article

Registration

January 10, 2026

Czech Republic Act No. 171/2022: Medical Devices Regulation Implementation and National Provisions

Act No. 171/2022 Sb. transposes EU MDR 2017/745 into Czech law, defining national competent authority roles, notified body designation, registration obligations, language requirements, advertising rules, vigilance reporting, and penalties, effective from 2022.

Read article

Post Market Surveillance

November 10, 2025

Czech Republic Decree No. 171/2021: Detailed Requirements for Medical Device Vigilance and Market Surveillance

Decree No. 171/2021 Sb. sets detailed national rules in Czechia for vigilance reporting of medical devices, including timelines, content of reports, serious incident definitions, trend reporting, field safety corrective actions, and SÚKL coordination procedures, supplementing EU MDR requirements.

Read article

Registration

September 12, 2025

Czech Republic Act No. 89/2021: Key Amendments to Pharmaceuticals Act Supporting MDR Implementation

Act No. 89/2021 Sb. introduces essential changes to the Czech Pharmaceuticals Act to facilitate full application of EU MDR 2017/745, covering updated definitions, SÚKL authority expansion, vigilance integration, advertising prohibitions, clinical investigation rules, and higher penalties for non-compliance.

Read article

Registration

August 5, 2025

Czech Republic Act No. 90/2021: Amendments to the Pharmaceuticals Act for EU MDR Alignment

Act No. 90/2021 Sb. amends the Czech Pharmaceuticals Act to align with EU Medical Device Regulation (MDR) 2017/745, updating definitions, vigilance obligations, advertising rules, competent authority powers (SÚKL), clinical investigation procedures, and penalties for medical devices.

Read article